Skip to main content
Atrás
Watch Compare

PRECISION BIOSCIENCES INC

Calidad de datos: 100%
DTIL
Nasdaq Manufacturing Chemicals
$6.67
▲ $0.06 (0.91%)
Cap. Mercado: 166.95 M
Precio
$6.47
Cap. Mercado
166.95 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Revenue declined -26.20% annually over 5 years
Earnings declined -737.98% over the past year
Negative free cash flow of -65.84 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 23.92%

Crecimiento

Revenue Growth (5Y)
-26.20%
Below sector avg (1.82%)
Revenue (1Y)-50.12%
Earnings (1Y)-737.98%
FCF Growth (3Y)N/A

Calidad

Return on Equity
-180.41%
Below sector avg (-53.34%)
ROIC-47.39%
Net Margin-133.45%
Op. Margin-152.19%

Seguridad

Debt / Equity
N/A
Current Ratio3.45
Interest Coverage-36.67

Valoración

PE (TTM)
-3.65
Below sector avg (-1.47)
P/B Ratio10.04
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -3.7 -1.5
P/B 10.0 1.6
ROE % -180.4 -53.3
Net Margin % -133.5 -41.5
Rev Growth 5Y % -26.2 1.8
D/E — 0.3

Precio Objetivo de Analistas

4 analistas
Buy
Actual
$6.67
+379.8%
Objetivo
$32.00
$19.00
$24.50
$60.00
Pronóstico
P/E Futuro -1.96
EPS Futuro -$3.40
Ingresos Est. 12.90 M

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$3.40
-$3.70 – -$3.10
 12.90 M 2
FY2026 -$3.53
-$3.53 – -$3.53
 13.08 M 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.64 $1.01 +256.4%
Q32025 -$2.21 -$1.84 +16.7%
Q22025 -$2.21 -$2.13 +3.4%
Q12025 -$2.42 -$2.21 +8.7%

ETFs Holding This Stock

JMCGX JMCGX
1.30% weight
JMIGX JMIGX
1.30% weight
JSCGX JSCGX
0.51% weight
JSIGX JSIGX
0.51% weight
BRUSX BRUSX
0.28% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -50.12% Revenue Growth (3Y) -16.14%
Earnings Growth (1Y) -737.98% Earnings Growth (3Y) N/A
Revenue Growth (5Y) -26.20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 34.26 M Net Income (TTM) -45.72 M
ROE -180.41% ROA -45.17%
Gross Margin N/A Operating Margin -152.19%
Net Margin -133.45% Free Cash Flow (TTM) -65.84 M
ROIC -47.39% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.45
Interest Coverage -36.67 Asset Turnover 0.34
Working Capital 36.71 M Tangible Book Value 15.65 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.65 Forward P/E N/A
P/B Ratio 10.04 P/S Ratio 4.87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -39.44%
Market Cap 166.95 M Enterprise Value 122.08 M
Per Share
EPS (Diluted TTM) -3.56 Revenue / Share 1.33
FCF / Share -2.55 OCF / Share -2.55
EPS CAGR (1Y) -442.31% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 144.00%
SBC-Adj. FCF -77.19 M Growth Momentum -23.92

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 34.26 M 68.70 M 48.73 M 25.10 M 115.53 M
Net Income -45.72 M 7.17 M -61.32 M -111.64 M -30.60 M
EPS (Diluted) -3.56 1.04 -15.96 -1.27 —
Gross Profit — — — — —
Operating Income -52.15 M -26.16 M -43.74 M -100.37 M -39.40 M
EBITDA — — — — —
R&D Expenses 54.17 M 59.56 M 53.38 M 83.94 M 115.24 M
SG&A Expenses — — — — —
D&A 1.47 M 3.40 M 6.82 M 7.80 M 8.98 M
Interest Expense 1.42 M 1.78 M 2.23 M 1.11 M 132,000.0
Income Tax 0.0 — — — 23,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 154.42 M 136.39 M 159.78 M 238.17 M 211.50 M
Total Liabilities 62.17 M 80.00 M 140.92 M 177.74 M 120.33 M
Shareholders' Equity 92.25 M 56.39 M 18.86 M 60.43 M 91.17 M
Total Debt — — 22.22 M 22.22 M 2.48 M
Cash & Equivalents 110.82 M 85.90 M 116.68 M 189.58 M 143.66 M
Current Assets 118.74 M 94.99 M 136.36 M 199.11 M 161.75 M
Current Liabilities 8.91 M 14.98 M 49.99 M 59.66 M 35.98 M